Mefloquine: the benefits outweigh the risks
نویسندگان
چکیده
منابع مشابه
Mefloquine: the benefits outweigh the risks.
Introduction extensive and mefloquine is not detectable in the CSF. The drug is very slowly eliminated, mainly as a carboxylic acid metabolite, with a half-time of about 1 Falciparum malaria remains one of the world’s biggest killers, accounting for about 2.1 million deaths in 1995— month. It is excreted in breast milk [2]. Mefloquine is effective against many isolates of about 4% of all global...
متن کاملAntidepressant Pharmacotherapy – Do the Benefits Outweigh the Risks?
Major depressive disorder (MDD) is a debilitating and often recurrent psychiatric illness that impacts the lives of millions. Approximately 20 percent of individuals will experience at least one depressive episode during their lives, and the high rates of chronic morbidity (depressive episodes typically last for several months) and mortality (owing to suicide) attributed to this disorder consti...
متن کاملGenetically modified organisms: do the benefits outweigh the risks?
UNLABELLED The objective of this literature review is to analyze the implications of using genetically modified organisms (GMOs) as well as international and European position regarding such organisms. METHOD Review of international and European legal requirements and ethical guidelines and relevant publications, found and accessed with the help of PubMed and Lund University Library databases...
متن کاملMonthly Patch Release Schedules: Do the Benefits Outweigh the Risks?
This paper provides a comprehensive discussion on patch schedules. This discussion occurs over two parts. The first analyses existing implementations of patch schedules with a focus on Microsoft’s monthly patch schedule. The arguments for patch schedules, namely increased patch quality and better planning within organisations are analysed and the impact of the type of disclosure investigated. I...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 1996
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1996.tb00002.x